| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $192.1M | — | +13.6% |
| Cost of Revenue | $55.6M | — | +4.6% |
| Gross Profit | $136.5M | — | +17.7% |
| R&D Expense | $17.6M | — | +5.9% |
| SG&A Expense | $137.1M | — | +7.9% |
| Operating Income | -$22.6M | — | +49.0% |
| Interest Expense | $11.7M | — | +49.5% |
| Pre-tax Income | -$33.9M | — | +34.9% |
| Income Tax | $50K | — | +178.1% |
| Net Income | -$33.9M | — | +34.7% |
| EPS (Basic) | -$0.22 | — | +37.1% |
| EPS (Diluted) | -$0.22 | — | +37.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $139.9M | -13.0% | -8.7% |
| Accounts Receivable | $106.4M | +9.3% | +18.9% |
| Inventory | $186.0M | +9.8% | +8.9% |
| Current Assets | $456.2M | +1.2% | +4.9% |
| Total Assets | $799.5M | +1.0% | +1.8% |
| Current Liabilities | $240.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.3M | — | +125.6% |
| Capital Expenditures | $12.1M | — | +21.7% |
| Investing Cash Flow | -$19.9M | — | -71.3% |
| Financing Cash Flow | -$1.8M | — | -105.8% |
| Free Cash Flow | -$10.8M | — | +27.9% |
| +52.2% |
| Long-term Debt | $573.4M | +1.3% | +4.6% |
| Stockholders' Equity | -$5.3M | -143.0% | +93.8% |